Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Sasol Shares Face Analyst Scrutiny Amid Cash Flow Concerns

Robert Sasse by Robert Sasse
September 24, 2025
in Analysis, Chemicals, Energy & Oil
0
Sasol Stock
0
SHARES
132
VIEWS
Share on FacebookShare on Twitter

Morgan Stanley has issued a significant downgrade for South African energy and chemicals group Sasol, shifting its investment stance and lowering the price target. The bank’s revised assessment points to persistent cash flow challenges and deep-seated structural issues within the company’s domestic operations as primary causes for concern.

Revised Rating and Price Target

In a move that underscores growing apprehension, Morgan Stanley adjusted its rating for Sasol from “Overweight” to “Equal-weight” this past Monday. Concurrently, the firm slashed its price target significantly, from 140 South African Rand to 120 Rand. The analysts justified this decision by highlighting disappointing projections for free cash flow in 2026 and 2027, which are anticipated to be a mere 5 to 6 Rand per share. This level of cash generation would imply a valuation multiple of approximately twenty times earnings.

The financial institution’s report suggests that one-off, short-term factors are currently masking the underlying weakness in Sasol’s fundamental ability to generate cash. It noted that debt repayments scheduled for the 2025 fiscal year are largely dependent on a payment from Transnet, fluctuations in working capital, and dividend receipts—all of which are considered temporary sources of funds.

Operational Headwinds and Strategic Challenges

The company is confronting a complex array of operational pressures. Softer global oil and chemical markets are squeezing profit margins, while a stronger South African Rand is increasing the cost of its exports. However, the most significant threats are structural.

Securing a reliable and affordable supply of key raw materials has become a critical vulnerability. Natural gas production in Mozambique is declining, and replacement coal is becoming both more expensive and scarce. Compounding this, Sasol’s own coal production volumes are experiencing a structural downturn. The profitability of its operations is further pressured by rising carbon taxes within South Africa.

Morgan Stanley expresses skepticism regarding Sasol’s ability to successfully navigate these structural challenges. Reflecting this view, the bank reduced its earnings forecasts for 2026 and 2027 by nearly one-fifth. This downward revision is attributed to expectations of lower coal and chemical output, combined with adverse currency effects.

Should investors sell immediately? Or is it worth buying Sasol?

A Glimmer of Hope in Recent Financials

Despite the cautious forward outlook, Sasol demonstrated a notable financial turnaround in its most recent fiscal year, which concluded on June 30, 2025. The company swung from a substantial net loss of 44.3 billion Rand to a net profit of 6.8 billion Rand. This performance fueled a share price recovery of approximately 39% over the year, effectively halting a three-year downward trend.

Key Financial Metrics for Fiscal Year 2025:
* Net Profit: 6.8 billion Rand (a reversal from a loss of 44.3 billion Rand)
* Earnings Per Share: 10.60 Rand (compared to a loss of 69.94 Rand)
* Free Cash Flow: Increased by 75% year-over-year
* Net Debt: $3.7 billion (an 11% reduction)

Although debt levels have decreased, net debt remains above the $3 billion threshold that management has identified as a prerequisite for the potential reinstatement of dividend payments. The company’s leadership now targets achieving this goal by the 2027/2028 period.

New Strategic Direction

Under the leadership of CEO Simon Baloyi, Sasol is pursuing a strategic pivot. The new approach emphasizes increased coal usage, a reduced reliance on gas, and a sharpened focus on renewable energy sources. The strategy aims to cut emissions by 30% before 2030 while simultaneously boosting production at the Secunda facility by a minimum of 4.5%.

Progress is already underway, with Sasol having secured 920 megawatts of renewable energy capacity. This is a step toward its ambitious target of 2 gigawatts by 2030. This transition is designed not only to improve the company’s environmental footprint but also to lower its long-term energy costs.

Sasol’s equity now stands at a critical juncture. While recent operational improvements are commendable, the scale of the structural challenges remains substantial. The stock’s ability to sustain its recovery will largely depend on management’s success in mitigating raw material risks and effectively executing its decarbonization strategy.

Ad

Sasol Stock: Buy or Sell?! New Sasol Analysis from March 25 delivers the answer:

The latest Sasol figures speak for themselves: Urgent action needed for Sasol investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Sasol: Buy or sell? Read more here...

Tags: Sasol
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock
AI & Quantum Computing

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock
Analysis

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Next Post
SQM Stock

Chile's Lithium Sector Poised for Historic State-Led Transformation

Oncology Institute Stock

Oncology Institute Shares Surge on Government Program Success

180 Life Sciences Stock

Ethereum Treasury Firm's Bold Buyback Plan Raises Alarm

Recommended

Oracle Stock

Oracle Shares Face Sector-Wide Pressure Despite Solid Long-Term Chart

7 months ago
Telecommunications Industry stock Trading

Globalstar Forecasts Strong Financial Performance and Growth Initiatives for 2024

2 years ago
Pulmonx Corp Stock

Pulmonx Shares Surge on Leadership Shakeup and Upbeat Forecast

5 months ago
Healthcare-sector

Analysts Divided on GE HealthCare Technologies Evaluating the Potential of the Stock

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

PagerDuty Charts a New Course with Autonomous AI Systems

Trending

Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

by Jackson Burston
March 25, 2026
0

The healthcare technology company Evolent Health is making a strategic push into artificial intelligence, appointing a seasoned...

MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Hain Celestial Stock

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026
Technology Select Sector SPDR® Fund Stock

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Evolent Health Bets on AI Leadership Amid Share Price Decline
  • MongoDB Strengthens Leadership Amid AI-Driven Growth Phase
  • Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com